A Functional Variomics Tool for Discovering Drug-Resistance Genes and Drug Targets

Cell Reports

Volumn 3, Issue 2, 2013, Pages 577-585

  Huang, Zhiwei ^a,b   Chen, Kaifu ^a   Zhang, Jianhuai ^a   Li, Yongxiang ^a   Wang, Hui ^a   Cui, Dandan ^a   Tang, Jiangwu ^c   Liu, Yong ^c   Shi, Xiaomin ^a   Li, Wei ^a   Liu, Dan ^a   Chen, Rui ^a   Sucgang, Richard S ^a   Pan, Xuewen ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b DONGHUA UNIVERSITY   (China)

^c INSTITUTE OF PLANT PROTECTION AND MICROBIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CYCLOHEXIMIDE; FILIPIN; MEMBRANE PROTEIN; NATAMYCIN; NYSTATIN; PMP3 PROTEIN; RAPAMYCIN; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; DRUG BINDING SITE; DRUG MECHANISM; DRUG RESISTANCE; DRUG TARGETING; FUNCTIONAL VARIOMICS TECHNOLOGY; GENE EXPRESSION; GENE MUTATION; GENETIC VARIABILITY; HIGH THROUGHPUT SCREENING; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; SACCHAROMYCES CEREVISIAE; TECHNOLOGY;

ALLELES; AMPHOTERICIN B; ANTIFUNGAL AGENTS; CELL CYCLE PROTEINS; CYCLOHEXIMIDE; DRUG RESISTANCE, MICROBIAL; MUTATION; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEOLIPIDS; RIBOSOMAL PROTEINS; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; SIROLIMUS;

SACCHAROMYCES CEREVISIAE;

EID: 84874263762     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2013.01.019     Document Type: Article

References (49)

1. Albert T.J., Dailidiene D., Dailide G., Norton J.E., Kalia A., Richmond T.A., Molla M., Singh J., Green R.D., Berg D.E. Mutation discovery in bacterial genomes: metronidazole resistance in Helicobacter pylori. Nat. Methods 2005, 2:951-953.
2. Baginski M., Czub J. Amphotericin B and its new derivatives-mode of action. Curr. Drug Metab. 2009, 10:459-469.
3. Barnes G., Hansen W.J., Holcomb C.L., Rine J. Asparagine-linked glycosylation in Saccharomyces cerevisiae: genetic analysis of an early step. Mol. Cell. Biol. 1984, 4:2381-2388.
4. Bastidas R.J., Shertz C.A., Lee S.C., Heitman J., Cardenas M.E. Rapamycin exerts antifungal activity in vitro and in vivo against Mucor circinelloides via FKBP12-dependent inhibition of Tor. Eukaryot. Cell 2012, 11:270-281.
5. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Series B Stat. Methodol. 1995, 57:289-300.
6. Benjamini Y., Yekutieli D. The control of the false discovery rate in multiple testing under dependency. Ann. Stat. 2001, 29:1165-1188.
7. Bolard J. How do the polyene macrolide antibiotics affect the cellular membrane properties?. Biochim. Biophys. Acta 1986, 864:257-304.
8. Brachmann C.B., Davies A., Cost G.J., Caputo E., Li J., Hieter P., Boeke J.D. Designer deletion strains derived from Saccharomyces cerevisiae S288C: a useful set of strains and plasmids for PCR-mediated gene disruption and other applications. Yeast 1998, 14:115-132.
9. Broughton M.C., Bard M., Lees N.D. Polyene resistance in ergosterol producing strains of Candida albicans. Mycoses 1991, 34:75-83.
10. Butcher R.A., Bhullar B.S., Perlstein E.O., Marsischky G., LaBaer J., Schreiber S.L. Microarray-based method for monitoring yeast overexpression strains reveals small-molecule targets in TOR pathway. Nat. Chem. Biol. 2006, 2:103-109.
11. Cardenas M.E., Heitman J. FKBP12-rapamycin target TOR2 is a vacuolar protein with an associated phosphatidylinositol-4 kinase activity. EMBO J. 1995, 14:5892-5907.
12. Chen K., Xi Y., Pan X., Li Z., Kaestner K., Tyler J., Dent S., He X., Li W. DANPOS: Dynamic analysis of nucleosome position and occupancy by sequencing. Genome Res. 2012, Published online December 20, 2012. 10.1101/gr.142067.112.
13. Chiu M.I., Katz H., Berlin V. RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex. Proc. Natl. Acad. Sci. USA 1994, 91:12574-12578.
14. Choi J., Chen J., Schreiber S.L., Clardy J. Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP. Science 1996, 273:239-242.
15. Costanzo M., Baryshnikova A., Bellay J., Kim Y., Spear E.D., Sevier C.S., Ding H., Koh J.L., Toufighi K., Mostafavi S., et al. The genetic landscape of a cell. Science 2010, 327:425-431.
16. Cruz M.C., Cavallo L.M., Görlach J.M., Cox G., Perfect J.R., Cardenas M.E., Heitman J. Rapamycin antifungal action is mediated via conserved complexes with FKBP12 and TOR kinase homologs in Cryptococcus neoformans. Mol. Cell. Biol. 1999, 19:4101-4112.
17. de Kruijff B., Demel R.A. Polyene antibiotic-sterol interactions in membranes of Acholeplasma laidlawii cells and lecithin liposomes. 3. Molecular structure of the polyene antibiotic-cholesterol complexes. Biochim. Biophys. Acta 1974, 339:57-70.
18. Dumont F.J., Staruch M.J., Grammer T., Blenis J., Kastner C.A., Rupprecht K.M. Dominant mutations confer resistance to the immunosuppressant, rapamycin, in variants of a T cell lymphoma. Cell. Immunol. 1995, 163:70-79.
19. Erez O., Kahana C. Deletions of SKY1 or PTK2 in the Saccharomyces cerevisiae trk1Δtrk2Δ mutant cells exert dual effect on ion homeostasis. Biochem. Biophys. Res. Commun. 2002, 295:1142-1149.
20. Giaever G., Shoemaker D.D., Jones T.W., Liang H., Winzeler E.A., Astromoff A., Davis R.W. Genomic profiling of drug sensitivities via induced haploinsufficiency. Nat. Genet. 1999, 21:278-283.
21. Giaever G., Chu A.M., Ni L., Connelly C., Riles L., Véronneau S., Dow S., Lucau-Danila A., Anderson K., André B., et al. Functional profiling of the Saccharomyces cerevisiae genome. Nature 2002, 418:387-391.
22. Gietz R.D., Sugino A. New yeast-Escherichia coli shuttle vectors constructed with in vitro mutagenized yeast genes lacking six-base pair restriction sites. Gene 1988, 74:527-534.
23. Gray K.C., Palacios D.S., Dailey I., Endo M.M., Uno B.E., Wilcock B.C., Burke M.D. Amphotericin primarily kills yeast by simply binding ergosterol. Proc. Natl. Acad. Sci. USA 2012, 109:2234-2239.
24. Heitman J., Movva N.R., Hall M.N. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 1991, 253:905-909.
25. Ho C.H., Magtanong L., Barker S.L., Gresham D., Nishimura S., Natarajan P., Koh J.L., Porter J., Gray C.A., Andersen R.J., et al. A molecular barcoded yeast ORF library enables mode-of-action analysis of bioactive compounds. Nat. Biotechnol. 2009, 27:369-377.
26. Huang Z., Sucgang R.S., Lin Y.Y., Shi X., Boeke J.D., Pan X. Plasmid-chromosome shuffling for non-deletion alleles in yeast. Nat. Methods 2008, 5:167-169.
27. Jensen-Pergakes K.L., Kennedy M.A., Lees N.D., Barbuch R., Koegel C., Bard M. Sequencing, disruption, and characterization of the Candida albicans sterol methyltransferase (ERG6) gene: drug susceptibility studies in erg6 mutants. Antimicrob. Agents Chemother. 1998, 42:1160-1167.
28. Katzmann D.J., Burnett P.E., Golin J., Mahé Y., Moye-Rowley W.S. Transcriptional control of the yeast PDR5 gene by the PDR3 gene product. Mol. Cell. Biol. 1994, 14:4653-4661.
29. Käufer N.F., Fried H.M., Schwindinger W.F., Jasin M., Warner J.R. Cycloheximide resistance in yeast: the gene and its protein. Nucleic Acids Res. 1983, 11:3123-3135.
30. Kelly S.L., Lamb D.C., Taylor M., Corran A.J., Baldwin B.C., Powderly W.G. Resistance to amphotericin B associated with defective sterol delta 8->7 isomerase in a Cryptococcus neoformans strain from an AIDS patient. FEMS Microbiol. Lett. 1994, 122:39-42.
31. Lorenz M.C., Heitman J. TOR mutations confer rapamycin resistance by preventing interaction with FKBP12-rapamycin. J. Biol. Chem. 1995, 270:27531-27537.
32. Meyers S., Schauer W., Balzi E., Wagner M., Goffeau A., Golin J. Interaction of the yeast pleiotropic drug resistance genes PDR1 and PDR5. Curr. Genet. 1992, 21:431-436.
33. + and increased salt sensitivity in Arabidopsis thaliana plants. Planta 2005, 222:1001-1009.
34. Navarre C., Goffeau A. Membrane hyperpolarization and salt sensitivity induced by deletion of PMP3, a highly conserved small protein of yeast plasma membrane. EMBO J. 2000, 19:2515-2524.
35. Pan X., Yuan D.S., Xiang D., Wang X., Sookhai-Mahadeo S., Bader J.S., Hieter P., Spencer F., Boeke J.D. A robust toolkit for functional profiling of the yeast genome. Mol. Cell 2004, 16:487-496.
36. Pan X., Ye P., Yuan D.S., Wang X., Bader J.S., Boeke J.D. A DNA integrity network in the yeast Saccharomyces cerevisiae. Cell 2006, 124:1069-1081.
37. Rask-Andersen M., Almén M.S., Schiöth H.B. Trends in the exploitation of novel drug targets. Nat. Rev. Drug Discov. 2011, 10:579-590.
38. Rine J., Hansen W., Hardeman E., Davis R.W. Targeted selection of recombinant clones through gene dosage effects. Proc. Natl. Acad. Sci. USA 1983, 80:6750-6754.
39. Sabatini D.M., Erdjument-Bromage H., Lui M., Tempst P., Snyder S.H. RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell 1994, 78:35-43.
40. Schmidt A., Beck T., Koller A., Kunz J., Hall M.N. The TOR nutrient signalling pathway phosphorylates NPR1 and inhibits turnover of the tryptophan permease. EMBO J. 1998, 17:6924-6931.
41. Schneider-Poetsch T., Ju J., Eyler D.E., Dang Y., Bhat S., Merrick W.C., Green R., Shen B., Liu J.O. Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin. Nat. Chem. Biol. 2010, 6:209-217.
42. Smith A.M., Heisler L.E., Mellor J., Kaper F., Thompson M.J., Chee M., Roth F.P., Giaever G., Nislow C. Quantitative phenotyping via deep barcode sequencing. Genome Res. 2009, 19:1836-1842.
43. te Welscher Y.M., ten Napel H.H., Balagué M.M., Souza C.M., Riezman H., de Kruijff B., Breukink E. Natamycin blocks fungal growth by binding specifically to ergosterol without permeabilizing the membrane. J. Biol. Chem. 2008, 283:6393-6401.
44. Wacker S.A., Houghtaling B.R., Elemento O., Kapoor T.M. Using transcriptome sequencing to identify mechanisms of drug action and resistance. Nat. Chem. Biol. 2012, 8:235-237.
45. Wang L.Y., Shiozaki K. The fission yeast stress MAPK cascade regulates the pmp3+ gene that encodes a highly conserved plasma membrane protein. FEBS Lett. 2006, 580:2409-2413.
46. Winzeler E.A., Shoemaker D.D., Astromoff A., Liang H., Anderson K., Andre B., Bangham R., Benito R., Boeke J.D., Bussey H., et al. Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science 1999, 285:901-906.
47. Yildirim M.A., Goh K.I., Cusick M.E., Barabási A.L., Vidal M. Drug-target network. Nat. Biotechnol. 2007, 25:1119-1126.
48. Young L.Y., Hull C.M., Heitman J. Disruption of ergosterol biosynthesis confers resistance to amphotericin B in Candida lusitaniae. Antimicrob. Agents Chemother. 2003, 47:2717-2724.
49. Zhang Y., Liu T., Meyer C.A., Eeckhoute J., Johnson D.S., Bernstein B.E., Nusbaum C., Myers R.M., Brown M., Li W., Liu X.S. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 2008, 9:R137. 10.1186/gb-2008-9-9-r137.